normethadone

0 marketed 1 in Phase 2

This page covers all normethadone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(2) dopamine receptor, D(3) dopamine receptor, Mu-type opioid receptor.

Targets

D(2) dopamine receptor, D(3) dopamine receptor, Mu-type opioid receptor

Phase 2 pipeline (1)

Patent intelligence